Candida Biofilms: Threats, Challenges, and Promising Strategies
- PMID: 29487851
- PMCID: PMC5816785
- DOI: 10.3389/fmed.2018.00028
Candida Biofilms: Threats, Challenges, and Promising Strategies
Abstract
Candida species are fungal pathogens known for their ability to cause superficial and systemic infections in the human host. These pathogens are able to persist inside the host due to the development of pathogenicity and multidrug resistance traits, often leading to the failure of therapeutic strategies. One specific feature of Candida species pathogenicity is their ability to form biofilms, which protects them from external factors such as host immune system defenses and antifungal drugs. This review focuses on the current threats and challenges when dealing with biofilms formed by Candida albicans, Candida glabrata, Candida tropicalis, and Candida parapsilosis, highlighting the differences between the four species. Biofilm characteristics depend on the ability of each species to produce extracellular polymeric substances (EPS) and display dimorphic growth, but also on the biofilm substratum, carbon source availability and other factors. Additionally, the transcriptional control over processes like adhesion, biofilm formation, filamentation, and EPS production displays great complexity and diversity within pathogenic yeasts of the Candida genus. These differences not only have implications in the persistence of colonization and infections but also on antifungal resistance typically found in Candida biofilm cells, potentiated by EPS, that functions as a barrier to drug diffusion, and by the overexpression of drug resistance transporters. The ability to interact with different species in in vivo Candida biofilms is also a key factor to consider when dealing with this problem. Despite many challenges, the most promising strategies that are currently available or under development to limit biofilm formation or to eradicate mature biofilms are discussed.
Keywords: Candida genus; antibiofilm strategies; antifungal resistance; biofilm formation; biofilm regulators; multi-species biofilm.
Figures


Similar articles
-
Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.J Mycol Med. 2020 Apr;30(1):100911. doi: 10.1016/j.mycmed.2019.100911. Epub 2019 Nov 7. J Mycol Med. 2020. PMID: 32008964
-
Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.Med Mycol. 2009 Nov;47(7):681-9. doi: 10.3109/13693780802549594. Med Mycol. 2009. PMID: 19888800
-
Relative Abundances of Candida albicans and Candida glabrata in In Vitro Coculture Biofilms Impact Biofilm Structure and Formation.Appl Environ Microbiol. 2018 Apr 2;84(8):e02769-17. doi: 10.1128/AEM.02769-17. Print 2018 Apr 15. Appl Environ Microbiol. 2018. PMID: 29427422 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Biofilms and vulvovaginal candidiasis.Colloids Surf B Biointerfaces. 2019 Feb 1;174:110-125. doi: 10.1016/j.colsurfb.2018.11.011. Epub 2018 Nov 7. Colloids Surf B Biointerfaces. 2019. PMID: 30447520 Review.
Cited by
-
Comparative analysis of enzymatic profiles and biofilm formation in clinical and environmental Candida kefyr isolates.Environ Microbiol Rep. 2024 Jun;16(3):e13282. doi: 10.1111/1758-2229.13282. Environ Microbiol Rep. 2024. PMID: 38923398 Free PMC article.
-
Synergistic Effect of Plant Compounds in Combination with Conventional Antimicrobials against Biofilm of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp.Pharmaceuticals (Basel). 2023 Oct 30;16(11):1531. doi: 10.3390/ph16111531. Pharmaceuticals (Basel). 2023. PMID: 38004397 Free PMC article. Review.
-
Synthetic Pesticides Used in Agricultural Production Promote Genetic Instability and Metabolic Variability in Candida spp.Genes (Basel). 2020 Jul 24;11(8):848. doi: 10.3390/genes11080848. Genes (Basel). 2020. PMID: 32722318 Free PMC article.
-
The Antifungal and Antibiofilm Activities of Caffeine against Candida albicans on Polymethyl Methacrylate Denture Base Material.Biomedicines. 2022 Aug 25;10(9):2078. doi: 10.3390/biomedicines10092078. Biomedicines. 2022. PMID: 36140179 Free PMC article.
-
Utilizing Liposomal Quercetin and Gallic Acid in Localized Treatment of Vaginal Candida Infections.Pharmaceutics. 2019 Dec 20;12(1):9. doi: 10.3390/pharmaceutics12010009. Pharmaceutics. 2019. PMID: 31861805 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources